ACE Inhibition with Moexipril: A Review of Potential Effects Beyond Blood Pressure Control

Author： Pines A.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.5, 2003-01, pp. : 351-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Outcomes and Angiotensin Converting Enzyme Inhibitors: Beyond Blood Pressure Control: Editorial to: “Secondary Prevention of Coronary Disease with ACE Inhibition—Does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?” by Remme et al.

By Verma Anil   Ventura Hector  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 109-111

Springer Publishing Company

Access to resources Recommend Favorite

Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?

By  

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite

Vasopeptidase Inhibition for Blood Pressure Control: Emerging Experience

By  

Current Pharmaceutical Design, Vol. 11, Iss. 25, 2005-10 ,pp. : 3293-3299

Bentham Science Publishers

Access to resources Recommend Favorite

Secondary Prevention of Coronary Disease with ACE Inhibition-does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?

By Remme Willem   Deckers Jaap   Fox Kim   Ferrari Roberto   Bertrand Michel   Simoons Maarten  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 161-170

Springer Publishing Company

Access to resources Recommend Favorite

Drugs Acting on Imidazoline Receptors: A Review of Their Pharmacology, Their Use in Blood Pressure Control and Their Potential Interest in Cardioprotection

By Bousquet P.   Feldman J.  

Drugs, Vol. 58, Iss. 5, 1999-11 ,pp. : 799-812

Adis International

Access to resources Recommend Favorite